Global Artificial Intelligence Pathology Diagnosis Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI10245084

Publication Date:

October 8, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Artificial Intelligence Pathology Diagnosis market size was valued at US$ million in 2023. With growing demand in downstream market, the Artificial Intelligence Pathology Diagnosis is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Artificial Intelligence Pathology Diagnosis market. Artificial Intelligence Pathology Diagnosis are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence Pathology Diagnosis. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence Pathology Diagnosis market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Artificial Intelligence Pathology Diagnosis market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence Pathology Diagnosis market. It may include historical data, market segmentation by Type (e.g., Histopathology, Cytopathology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence Pathology Diagnosis market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence Pathology Diagnosis market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence Pathology Diagnosis industry. This include advancements in Artificial Intelligence Pathology Diagnosis technology, Artificial Intelligence Pathology Diagnosis new entrants, Artificial Intelligence Pathology Diagnosis new investment, and other innovations that are shaping the future of Artificial Intelligence Pathology Diagnosis.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence Pathology Diagnosis market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence Pathology Diagnosis product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence Pathology Diagnosis market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence Pathology Diagnosis market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence Pathology Diagnosis market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence Pathology Diagnosis industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence Pathology Diagnosis market.
Market Segmentation:
Artificial Intelligence Pathology Diagnosis market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Histopathology
Cytopathology
Immunohistochemical Pathology
Molecular Pathology
Segmentation by application
Hospital
Diagnostic Laboratory
Training and Education
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aiforia
AIRA Matrix
Deep Bio
DoMore Diagnostics
Indica Labs
Mindpeak
Paige AI
Path AI
Tempus
Verily
Aignostics GmbH
Gestalt Diagnostics
Primma

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Pathology Diagnosis Market Size 2019-2030
2.1.2 Artificial Intelligence Pathology Diagnosis Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Artificial Intelligence Pathology Diagnosis Segment by Type
2.2.1 Histopathology
2.2.2 Cytopathology
2.2.3 Immunohistochemical Pathology
2.2.4 Molecular Pathology
2.3 Artificial Intelligence Pathology Diagnosis Market Size by Type
2.3.1 Artificial Intelligence Pathology Diagnosis Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Pathology Diagnosis Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence Pathology Diagnosis Segment by Application
2.4.1 Hospital
2.4.2 Diagnostic Laboratory
2.4.3 Training and Education
2.5 Artificial Intelligence Pathology Diagnosis Market Size by Application
2.5.1 Artificial Intelligence Pathology Diagnosis Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Pathology Diagnosis Market Size Market Share by Application (2019-2024)
3 Artificial Intelligence Pathology Diagnosis Market Size by Player
3.1 Artificial Intelligence Pathology Diagnosis Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Pathology Diagnosis Revenue by Players (2019-2024)
3.1.2 Global Artificial Intelligence Pathology Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence Pathology Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence Pathology Diagnosis by Regions
4.1 Artificial Intelligence Pathology Diagnosis Market Size by Regions (2019-2024)
4.2 Americas Artificial Intelligence Pathology Diagnosis Market Size Growth (2019-2024)
4.3 APAC Artificial Intelligence Pathology Diagnosis Market Size Growth (2019-2024)
4.4 Europe Artificial Intelligence Pathology Diagnosis Market Size Growth (2019-2024)
4.5 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence Pathology Diagnosis Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Pathology Diagnosis Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Pathology Diagnosis Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Pathology Diagnosis Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Pathology Diagnosis Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Pathology Diagnosis Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence Pathology Diagnosis by Country (2019-2024)
7.2 Europe Artificial Intelligence Pathology Diagnosis Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Pathology Diagnosis Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence Pathology Diagnosis by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Pathology Diagnosis Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence Pathology Diagnosis Market Forecast
10.1 Global Artificial Intelligence Pathology Diagnosis Forecast by Regions (2025-2030)
10.1.1 Global Artificial Intelligence Pathology Diagnosis Forecast by Regions (2025-2030)
10.1.2 Americas Artificial Intelligence Pathology Diagnosis Forecast
10.1.3 APAC Artificial Intelligence Pathology Diagnosis Forecast
10.1.4 Europe Artificial Intelligence Pathology Diagnosis Forecast
10.1.5 Middle East & Africa Artificial Intelligence Pathology Diagnosis Forecast
10.2 Americas Artificial Intelligence Pathology Diagnosis Forecast by Country (2025-2030)
10.2.1 United States Artificial Intelligence Pathology Diagnosis Market Forecast
10.2.2 Canada Artificial Intelligence Pathology Diagnosis Market Forecast
10.2.3 Mexico Artificial Intelligence Pathology Diagnosis Market Forecast
10.2.4 Brazil Artificial Intelligence Pathology Diagnosis Market Forecast
10.3 APAC Artificial Intelligence Pathology Diagnosis Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Pathology Diagnosis Market Forecast
10.3.2 Japan Artificial Intelligence Pathology Diagnosis Market Forecast
10.3.3 Korea Artificial Intelligence Pathology Diagnosis Market Forecast
10.3.4 Southeast Asia Artificial Intelligence Pathology Diagnosis Market Forecast
10.3.5 India Artificial Intelligence Pathology Diagnosis Market Forecast
10.3.6 Australia Artificial Intelligence Pathology Diagnosis Market Forecast
10.4 Europe Artificial Intelligence Pathology Diagnosis Forecast by Country (2025-2030)
10.4.1 Germany Artificial Intelligence Pathology Diagnosis Market Forecast
10.4.2 France Artificial Intelligence Pathology Diagnosis Market Forecast
10.4.3 UK Artificial Intelligence Pathology Diagnosis Market Forecast
10.4.4 Italy Artificial Intelligence Pathology Diagnosis Market Forecast
10.4.5 Russia Artificial Intelligence Pathology Diagnosis Market Forecast
10.5 Middle East & Africa Artificial Intelligence Pathology Diagnosis Forecast by Region (2025-2030)
10.5.1 Egypt Artificial Intelligence Pathology Diagnosis Market Forecast
10.5.2 South Africa Artificial Intelligence Pathology Diagnosis Market Forecast
10.5.3 Israel Artificial Intelligence Pathology Diagnosis Market Forecast
10.5.4 Turkey Artificial Intelligence Pathology Diagnosis Market Forecast
10.5.5 GCC Countries Artificial Intelligence Pathology Diagnosis Market Forecast
10.6 Global Artificial Intelligence Pathology Diagnosis Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Pathology Diagnosis Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Aiforia
11.1.1 Aiforia Company Information
11.1.2 Aiforia Artificial Intelligence Pathology Diagnosis Product Offered
11.1.3 Aiforia Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aiforia Main Business Overview
11.1.5 Aiforia Latest Developments
11.2 AIRA Matrix
11.2.1 AIRA Matrix Company Information
11.2.2 AIRA Matrix Artificial Intelligence Pathology Diagnosis Product Offered
11.2.3 AIRA Matrix Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AIRA Matrix Main Business Overview
11.2.5 AIRA Matrix Latest Developments
11.3 Deep Bio
11.3.1 Deep Bio Company Information
11.3.2 Deep Bio Artificial Intelligence Pathology Diagnosis Product Offered
11.3.3 Deep Bio Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Deep Bio Main Business Overview
11.3.5 Deep Bio Latest Developments
11.4 DoMore Diagnostics
11.4.1 DoMore Diagnostics Company Information
11.4.2 DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Product Offered
11.4.3 DoMore Diagnostics Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 DoMore Diagnostics Main Business Overview
11.4.5 DoMore Diagnostics Latest Developments
11.5 Indica Labs
11.5.1 Indica Labs Company Information
11.5.2 Indica Labs Artificial Intelligence Pathology Diagnosis Product Offered
11.5.3 Indica Labs Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Indica Labs Main Business Overview
11.5.5 Indica Labs Latest Developments
11.6 Mindpeak
11.6.1 Mindpeak Company Information
11.6.2 Mindpeak Artificial Intelligence Pathology Diagnosis Product Offered
11.6.3 Mindpeak Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mindpeak Main Business Overview
11.6.5 Mindpeak Latest Developments
11.7 Paige AI
11.7.1 Paige AI Company Information
11.7.2 Paige AI Artificial Intelligence Pathology Diagnosis Product Offered
11.7.3 Paige AI Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Paige AI Main Business Overview
11.7.5 Paige AI Latest Developments
11.8 Path AI
11.8.1 Path AI Company Information
11.8.2 Path AI Artificial Intelligence Pathology Diagnosis Product Offered
11.8.3 Path AI Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Path AI Main Business Overview
11.8.5 Path AI Latest Developments
11.9 Tempus
11.9.1 Tempus Company Information
11.9.2 Tempus Artificial Intelligence Pathology Diagnosis Product Offered
11.9.3 Tempus Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Tempus Main Business Overview
11.9.5 Tempus Latest Developments
11.10 Verily
11.10.1 Verily Company Information
11.10.2 Verily Artificial Intelligence Pathology Diagnosis Product Offered
11.10.3 Verily Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Verily Main Business Overview
11.10.5 Verily Latest Developments
11.11 Aignostics GmbH
11.11.1 Aignostics GmbH Company Information
11.11.2 Aignostics GmbH Artificial Intelligence Pathology Diagnosis Product Offered
11.11.3 Aignostics GmbH Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Aignostics GmbH Main Business Overview
11.11.5 Aignostics GmbH Latest Developments
11.12 Gestalt Diagnostics
11.12.1 Gestalt Diagnostics Company Information
11.12.2 Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Product Offered
11.12.3 Gestalt Diagnostics Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Gestalt Diagnostics Main Business Overview
11.12.5 Gestalt Diagnostics Latest Developments
11.13 Primma
11.13.1 Primma Company Information
11.13.2 Primma Artificial Intelligence Pathology Diagnosis Product Offered
11.13.3 Primma Artificial Intelligence Pathology Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Primma Main Business Overview
11.13.5 Primma Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂